Skip to main content
Fig. 11 | The Journal of Headache and Pain

Fig. 11

From: Therapeutic novelties in migraine: new drugs, new hope?

Fig. 11

Overview of the therapeutic gain* in percentage of patients with >‚ÄČ50% reduction in migraine days with anti-calcitonin gene-related peptide monoclonal antibodies. A darker bar indicates a higher dose. *Therapeutic gain is defined as the difference between percentage of patients in active group compared to percentage of patients in placebo group

Back to article page
\